lba: gilteritinib as post-transplant maintenance therapy in flt3-itd aml
Published 1 year ago • 166 plays • Length 1:43Download video MP4
Download video MP3
Similar videos
-
5:09
morpho: gilteritinib as post-transplant maintenance therapy in patients with flt3-itd aml
-
2:27
gilteritinib maintenance after allogeneic transplantation in flt3-mutated aml
-
1:59
optimizing the use of flt3 inhibitors in aml: sequencing, post-transplant maintenance & more
-
0:51
unmet needs in front-line therapy for patients with flt3-mutated aml
-
1:40
second-generation flt3 inhibitors in the treatment of flt3-itd aml
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
1:03
targeted therapies in newly diagnosed aml: bcl2, flt3 and idh inhibitors
-
10:03
penicillin molecular frequency (entertainment only)
-
9:45
discussing flt3-mutated aml: top ash data, triplets, and exciting future strategies
-
6:39
treatment failure and relapse in acute myeloid leukemia (aml)
-
2:34
randomised trial of the flt3 inhibitor gilteritinib as post-transplant maintenance for flt3-itd aml
-
6:24
gilteritinib in r/r aml
-
1:12
the value of flt3 inhibitors in aml and focus for future trial designs
-
1:57
insights into the treatment of patients with flt3-mutated aml & the role of maintenance therapy
-
3:13
preliminary results from the frida study: iadademstat and gilteritinib in flt3-mutated r/r aml
-
1:23
the promise of combining venetoclax with gilteritinib for the treatment of flt3-mutated aml
-
4:47
the use of flt3 inhibitors in aml
-
1:04
continuous treatment with flt3 inhibitors for patients with flt3-mutated aml undergoing allosct
-
3:03
prognostic impact of flt3-itd in older patients with aml
-
2:05
phase iii trial of azacitidine and gilteritinib in flt3 mutant aml
-
6:35
costem aml highlights: sct & mrd status, sorafenib maintenance & gilteritinib in flt3 aml
-
1:28
assaying flt3 variant allele frequency in aml to determine response to treatment